Case Reports
doi: 10.1111/j.1600-0420.2006.00779.x.
Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy
- PMID: 17083555
- DOI: 10.1111/j.1600-0420.2006.00779.x
Item in Clipboard
Case Reports
Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy
Acta Ophthalmol Scand.
2006 Dec.
Free article
No abstract available
Similar articles
-
Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.Acta Ophthalmol Scand. 2007 May;85(3):340-1. doi: 10.1111/j.1600-0420.2006.00832.x. Acta Ophthalmol Scand. 2007. PMID: 17488467 No abstract available.
-
Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin).Clin Exp Ophthalmol. 2006 Nov;34(8):802-3. doi: 10.1111/j.1442-9071.2006.01378.x. Clin Exp Ophthalmol. 2006. PMID: 17073910
-
Rapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab.Can J Ophthalmol. 2007 Apr;42(2):335-6. Can J Ophthalmol. 2007. PMID: 17392871 No abstract available.
-
Bevacizumab (Avastin) for the treatment of ocular disease.Surv Ophthalmol. 2009 May-Jun;54(3):372-400. doi: 10.1016/j.survophthal.2009.02.004. Surv Ophthalmol. 2009. PMID: 19422965 Review.
-
Bevacizumab (avastin) for the treatment of retinopathy of prematurity.Neonatal Netw. 2012 Jul-Aug;31(4):242-7. Neonatal Netw. 2012. PMID: 22763251 Review. No abstract available.
Cited by
-
Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.ScientificWorldJournal. 2012;2012:949535. doi: 10.1100/2012/949535. Epub 2012 Aug 1. ScientificWorldJournal. 2012. PMID: 22924029 Free PMC article. Review.
-
Role of intravitreal bevacizumab in the management of Eales' disease.Int Ophthalmol. 2010 Feb;30(1):57-61. doi: 10.1007/s10792-009-9292-0. Epub 2009 Jan 23. Int Ophthalmol. 2010. PMID: 19165424
-
Morphine promotes neovascularizing retinopathy in sickle transgeneic mice.Blood Adv. 2019 Apr 9;3(7):1073-1083. doi: 10.1182/bloodadvances.2018026898. Blood Adv. 2019. PMID: 30944099 Free PMC article.
-
Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy.Indian J Ophthalmol. 2008 May-Jun;56(3):259. doi: 10.4103/0301-4738.40380. Indian J Ophthalmol. 2008. PMID: 18417840 Free PMC article. No abstract available.
-
Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy.PLoS One. 2017 Aug 23;12(8):e0183320. doi: 10.1371/journal.pone.0183320. eCollection 2017. PLoS One. 2017. PMID: 28832635 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
